{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:52:47Z","timestamp":1768567967177,"version":"3.49.0"},"reference-count":30,"publisher":"Akademiai Kiado Zrt.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orvosi Hetilap"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:p>Biological response modifiers, especially tumour necrosis factor inhibitors have been proved to be very effective in the treatment of various immune mediated rheumatological, gastroenterological and dermatological diseases in the last 15 years. With their increasing use, the incidence of their adverse effects are more precisely defined. The aim of this cohort study was to analyse the adverse effects occurred within the study period in patients receiving biological therapy for rheumatological and dermatological autoimmune diseases. Methods: 324 patients within a 3 years study period were treated with biological response modifiers (adalimumab: 92, etanercept: 107, infliximab: 125). The primary diagnoses were rheumotoid arthritis (n = 174), ankylosing spondylitis (n = 60), psoriatic arthritis (n = 11), and psoriasis vulgaris (79). Results: Hypersensitive reactions were observed in 11 of the patients (3.4%), 7 of which were serious and needed treatment termination. Infections constituted the majority of side effects, which were localised to skin in 10 (3.1%) and to respiratory tract in 9 (2.8%). However, most of these were mild or moderate reactions. Malignant skin tumour developed in 1 case (0.3%) only. Drug induced inflammatory disorders occurred in some cases: onset of new psoriasis was observed in 1 and flares of the existing disease were detected in additional three. Lichenoid exanthema developed in one. (n = 5, 1.5%) Conclusion: The use of TNF-\u03b1 blockers may provoke a broad spectrum of dermatological side effects. Our results suggest that the majority of these are infectious and inflammatory disorders, the latter may relatively often appear as drug induced psoriasis. The occurrence of malignancies was very low in our series. Orv. Hetil., 2011, 152, 212\u2013220.<\/jats:p>","DOI":"10.1556\/oh.2011.28987","type":"journal-article","created":{"date-parts":[[2011,1,29]],"date-time":"2011-01-29T02:18:52Z","timestamp":1296267532000},"page":"212-220","source":"Crossref","is-referenced-by-count":12,"title":["Adverse events during biological therapy \u2013 focusing on dermatological side-effects"],"prefix":"10.1556","volume":"152","author":[{"given":"Gabriella","family":"Nagy","sequence":"first","affiliation":[{"name":"Miskolci Semmelweis Ign\u00e1c Eg\u00e9szs\u00e9g\u00fcgyi K\u00f6zpont Nonprofit Kft. Miskolc Csabai kapu 9\u201311. 3526"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Luk\u00e1cs","sequence":"additional","affiliation":[{"name":"Szent Ferenc K\u00f3rh\u00e1z Mozg\u00e1sszervi Rehabilit\u00e1ci\u00f3s Oszt\u00e1ly Miskolc"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1gnes","family":"Sziray","sequence":"additional","affiliation":[{"name":"Miskolci Semmelweis Ign\u00e1c Eg\u00e9szs\u00e9g\u00fcgyi K\u00f6zpont Nonprofit Kft. Miskolc Csabai kapu 9\u201311. 3526"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"Fazekas","sequence":"additional","affiliation":[{"name":"Szent Ferenc K\u00f3rh\u00e1z Mozg\u00e1sszervi Rehabilit\u00e1ci\u00f3s Oszt\u00e1ly Miskolc"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1gnes","family":"Flori\u00e1n","sequence":"additional","affiliation":[{"name":"Szent Ferenc K\u00f3rh\u00e1z Mozg\u00e1sszervi Rehabilit\u00e1ci\u00f3s Oszt\u00e1ly Miskolc"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Tam\u00e1si","sequence":"additional","affiliation":[{"name":"Szent Ferenc K\u00f3rh\u00e1z Mozg\u00e1sszervi Rehabilit\u00e1ci\u00f3s Oszt\u00e1ly Miskolc"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzs\u00e1nna","family":"K\u00e1rolyi","sequence":"additional","affiliation":[{"name":"Miskolci Semmelweis Ign\u00e1c Eg\u00e9szs\u00e9g\u00fcgyi K\u00f6zpont Nonprofit Kft. Miskolc Csabai kapu 9\u201311. 3526"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"atypb1","volume-title":"Evidence-based therapy of psoriasis: Focus on biologics","year":"2008"},{"key":"atypb2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1398-9995.2006.01058.x","volume":"61","year":"2006","journal-title":"Allergy"},{"key":"atypb3","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","year":"2006","journal-title":"JAMA"},{"key":"atypb4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/ard.2007.087288","volume":"68","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"atypb5","first-page":"1","volume":"23","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venerol."},{"key":"atypb6","first-page":"4","volume":"7","year":"2008","journal-title":"Hun. Immunol."},{"key":"atypb7","first-page":"1190","volume":"144","year":"2008","journal-title":"Arch. Dermatol."},{"key":"atypb8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa020888","volume":"348","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"atypb9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10067-008-0866-4","volume":"27","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"atypb10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","volume":"126","year":"2004","journal-title":"Gastroenterology"},{"key":"atypb11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-230X-9-66","volume":"9","year":"2009","journal-title":"BMC Gastroenterology"},{"key":"atypb12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/ard.2005.043158","volume":"65","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"atypb13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","volume":"146","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"atypb14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.2004.030528","volume":"64","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"atypb15","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.22056","volume":"54","year":"2006","journal-title":"Arthritis Rheum."},{"key":"atypb16","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1002\/art.24941","volume":"60","year":"2009","journal-title":"Arthritis Rheum."},{"key":"atypb17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/art.24506","volume":"61","year":"2009","journal-title":"Arthritis Rheum."},{"key":"atypb18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2005.06893.x","volume":"153","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"atypb19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/art.22504","volume":"56","year":"2007","journal-title":"Arthritis Rheum."},{"key":"atypb20","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/art.21386","volume":"52","year":"2005","journal-title":"Arthritis Rheum."},{"key":"atypb21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00403-006-0660-6","volume":"298","year":"2006","journal-title":"Arch. Dermatol. Res."},{"key":"atypb22","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","volume":"349","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"atypb23","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"atypb24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00128071-200809010-00001","volume":"9","year":"2008","journal-title":"Am. J. Clin. Dermatol."},{"key":"atypb25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","volume":"202","year":"2005","journal-title":"J. Exp. Med."},{"key":"atypb26","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","volume":"102","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"atypb27","first-page":"223","volume":"143","year":"2007","journal-title":"Arch. Dermatol."},{"key":"atypb28","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2036.2009.03955.x","volume":"29","year":"2009","journal-title":"Aliment Pharmacol. Ther."},{"key":"atypb29","first-page":"855","volume":"35","year":"2008","journal-title":"J. Rheumatol."},{"key":"atypb30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1468-3083.2007.02429.x","volume":"22","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venerol."}],"container-title":["Orvosi Hetilap"],"original-title":[],"language":"hu","link":[{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/OH.2011.28987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T07:16:11Z","timestamp":1740899771000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/oh.2011.28987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1556\/OH.2011.28987"],"URL":"https:\/\/doi.org\/10.1556\/oh.2011.28987","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}